Amide Technologies

Lately:1 news story in 90 daysFollow changes →

Facts

as of Nov 19, 2026

Advanced AFPS technology delivers fast, reliable synthesis of complex peptides—enabling novel structures and more effective clinical programs.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Financials

Funding rounds, investors and revenue on record.

$16.5MTotal raised
Venture - Series UnknownLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2023$16.5M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Money

Amide Technologies has $16.5M paid in by investors, lenders and donors.

$16.5MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Dec 2023 · Venture round
$16.5MPaid
Taxes
No public tax figures for this company or its entities.
People cost

Amide Technologies filed a median H-1B wage of $135k in 2026.

$135kMedian H-1B wage, 20261 casesSource ↗
Median H-1B wage by role, 2026scale to $135k
Senior Scientist · 1$135k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Milestones

Each milestone is dated by its source: registers, filings, the press